Practical advice on clinical decision making during neoadjuvant chemotherapy for primary breast cancer

H G Shenoy, M B Peter, Y A Masannat, B J G Dall, D Dodwell, K Horgan

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Neoadjuvant chemotherapy (NACT) is a useful approach in the treatment of many breast cancers. One of the main advantages of NACT is the possibility of breast conservation surgery in patients who would otherwise require a mastectomy. Most literature on NACT focuses on the effectiveness of different chemotherapy regimen and subsequent mastectomy rates. There is little guidance in the literature on aspects of individual patient management and decision making during NACT. This paper considers practical management advice where NACT is considered and adopted.

Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalEuropean Journal of Surgical Oncology
Volume18
Issue number1
Early online date29 Aug 2008
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Breast Neoplasms
Drug Therapy
Mastectomy
Clinical Decision-Making
Decision Making
Breast
Therapeutics

Keywords

  • Antineoplastic Agents/therapeutic use
  • Breast Neoplasms/drug therapy
  • Decision Making
  • Female
  • Humans
  • Neoadjuvant Therapy

Cite this

Practical advice on clinical decision making during neoadjuvant chemotherapy for primary breast cancer. / Shenoy, H G; Peter, M B; Masannat, Y A; Dall, B J G; Dodwell, D; Horgan, K.

In: European Journal of Surgical Oncology, Vol. 18, No. 1, 03.2009, p. 65-71.

Research output: Contribution to journalReview article

Shenoy, H G ; Peter, M B ; Masannat, Y A ; Dall, B J G ; Dodwell, D ; Horgan, K. / Practical advice on clinical decision making during neoadjuvant chemotherapy for primary breast cancer. In: European Journal of Surgical Oncology. 2009 ; Vol. 18, No. 1. pp. 65-71.
@article{9772902494cd4fa6b10deac78b61c520,
title = "Practical advice on clinical decision making during neoadjuvant chemotherapy for primary breast cancer",
abstract = "Neoadjuvant chemotherapy (NACT) is a useful approach in the treatment of many breast cancers. One of the main advantages of NACT is the possibility of breast conservation surgery in patients who would otherwise require a mastectomy. Most literature on NACT focuses on the effectiveness of different chemotherapy regimen and subsequent mastectomy rates. There is little guidance in the literature on aspects of individual patient management and decision making during NACT. This paper considers practical management advice where NACT is considered and adopted.",
keywords = "Antineoplastic Agents/therapeutic use, Breast Neoplasms/drug therapy, Decision Making, Female, Humans, Neoadjuvant Therapy",
author = "Shenoy, {H G} and Peter, {M B} and Masannat, {Y A} and Dall, {B J G} and D Dodwell and K Horgan",
year = "2009",
month = "3",
doi = "10.1016/j.suronc.2008.07.005",
language = "English",
volume = "18",
pages = "65--71",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Practical advice on clinical decision making during neoadjuvant chemotherapy for primary breast cancer

AU - Shenoy, H G

AU - Peter, M B

AU - Masannat, Y A

AU - Dall, B J G

AU - Dodwell, D

AU - Horgan, K

PY - 2009/3

Y1 - 2009/3

N2 - Neoadjuvant chemotherapy (NACT) is a useful approach in the treatment of many breast cancers. One of the main advantages of NACT is the possibility of breast conservation surgery in patients who would otherwise require a mastectomy. Most literature on NACT focuses on the effectiveness of different chemotherapy regimen and subsequent mastectomy rates. There is little guidance in the literature on aspects of individual patient management and decision making during NACT. This paper considers practical management advice where NACT is considered and adopted.

AB - Neoadjuvant chemotherapy (NACT) is a useful approach in the treatment of many breast cancers. One of the main advantages of NACT is the possibility of breast conservation surgery in patients who would otherwise require a mastectomy. Most literature on NACT focuses on the effectiveness of different chemotherapy regimen and subsequent mastectomy rates. There is little guidance in the literature on aspects of individual patient management and decision making during NACT. This paper considers practical management advice where NACT is considered and adopted.

KW - Antineoplastic Agents/therapeutic use

KW - Breast Neoplasms/drug therapy

KW - Decision Making

KW - Female

KW - Humans

KW - Neoadjuvant Therapy

U2 - 10.1016/j.suronc.2008.07.005

DO - 10.1016/j.suronc.2008.07.005

M3 - Review article

VL - 18

SP - 65

EP - 71

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 1

ER -